Since FXYD1 can inhibit the activity of Na, K-ATPase, overexpression of FXYD1 can cause typical neuropathological manifestations of RTT, such as a reduction in dendritic branches and dendritic spines. Here, FXYD1 is linked to Rett syndrome.